PLEASANTON, Calif.,
Oct. 7, 2021 /PRNewswire/ -- 10x
Genomics (Nasdaq: TXG) today announced it will report financial
results for the third quarter 2021 after market close on
Wednesday, November 3rd, 2021. The
company's management will webcast a corresponding conference call
beginning at 1:30 p.m. Pacific Time /
4:30 p.m. Eastern Time to discuss its
results, business developments and outlook.
Live audio of the webcast will be available on the "Investors"
section of the company website at: www.10xgenomics.com. The
webcast will be archived and available for replay for at least 45
days after the event.
About 10x Genomics
10x Genomics is a life science technology company building products
to interrogate, understand and master biology to advance human
health. The company's integrated solutions include instruments,
consumables and software for analyzing biological systems at a
resolution and scale that matches the complexity of biology. 10x
Genomics products have been adopted by researchers around the world
including in all of the top 100 global research institutions as
ranked by Nature in 2020 based on publications and all of the top
20 global pharmaceutical companies by 2020 research and development
spend and have been cited in over 2,800 research papers on
discoveries ranging from oncology to immunology and neuroscience.
The company's patent portfolio comprises more than 1,150 issued
patents and patent applications.
Disclosure Information
10x Genomics uses filings with the Securities and Exchange
Commission, its website (www.10xgenomics.com), press releases,
public conference calls, public webcasts and its social media
accounts as means of disclosing material non-public information and
for complying with its disclosure obligations under Regulation
FD.
View original
content:https://www.prnewswire.com/news-releases/10x-genomics-to-report-third-quarter-financial-results-on-november-3-2021-301395706.html
SOURCE 10x Genomics, Inc